Artivion (AORT) Total Non-Current Liabilities (2010 - 2026)

Artivion (AORT) reported Total Non-Current Liabilities of $423.5 million for Q1 2026, down 5.22% on a YoY basis from $446.9 million in Q1 2025, and up 6.77% quarter-over-quarter from $396.7 million in Q4 2025.

Artivion (AORT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Artivion has reported Total Non-Current Liabilities for 17 years, with the latest figure at $423.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 5.22% year-over-year to $423.5 million; the trailing twelve-month figure through Mar 2026 stood at $423.5 million (down 5.22% YoY), and the FY2025 full-year result was $396.7 million, down 21.43% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $423.5 million, up from $396.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $504.8 million in Q4 2024, with the low at $365.8 million in Q2 2025.
  • Historically, Total Non-Current Liabilities has averaged $452.5 million across 5 years, with a median of $446.9 million in 2025.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities increased 14.89% — and 2025, when it retreated 24.8%.
  • Artivion's Total Non-Current Liabilities stood at $438.1 million in 2022, then grew by 14.89% to $503.3 million in 2023, then advanced by 0.31% to $504.8 million in 2024, then retreated by 21.43% to $396.7 million in 2025, then increased by 6.77% to $423.5 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $423.5 million (Q1 2026), $396.7 million (Q4 2025), and $382.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 20.94 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 24.21 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 3.47 Bn
10 Artivion 1.02 Bn 961.48 Mn 75.45 Mn 423.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 423.53 Mn
Dec 31, 2025 396.67 Mn
Sep 30, 2025 382.43 Mn
Jun 30, 2025 365.79 Mn
Mar 31, 2025 446.86 Mn
Dec 31, 2024 504.84 Mn
Sep 30, 2024 489.93 Mn
Jun 30, 2024 486.43 Mn
Mar 31, 2024 442.60 Mn
Dec 31, 2023 503.28 Mn
Sep 30, 2023 495.24 Mn
Jun 30, 2023 487.88 Mn
Mar 31, 2023 431.96 Mn
Dec 31, 2022 438.07 Mn
Sep 30, 2022 480.97 Mn
Jun 30, 2022 438.96 Mn
Mar 31, 2022 477.64 Mn
Dec 31, 2021 442.92 Mn
Sep 30, 2021 494.87 Mn
Jun 30, 2021 496.42 Mn